🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Dayan Wang

Sun Yat-sen University

ORCID: 0000-0002-4990-1016

Also affiliated with Chinese Center For Disease Control and Prevention, The Seventh Affiliated Hospital of Sun Yat-sen University, National Institute for Viral Disease Control and Prevention

MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020

Antiviral Research(2022)10.1016/j.antiviral.2022.105281
Top 4%
5.0DataRank
Top 4%143 citations

Emi Takashita, Rod S. Daniels, Seiichiro Fujisaki, Lance Presser, Mira C. Patel +16 more

Papers

Driven by 6 papers — median percentile 96. Top paper: “Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020”.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020

Antiviral Research(2022)10.1016/j.antiviral.2022.105281
Top 4%
5.0DataRank
Top 4%143 citations

Emi Takashita, Rod S. Daniels, Seiichiro Fujisaki, Lance Presser, Mira C. Patel +16 more

A Novel Coronavirus from Patients with Pneumonia in China, 2019

New England Journal of Medicine(2020)10.1056/nejmoa2001017
N/A
1.5DataRank · unranked
21793 citations

Dingyu Zhang, Wenling Wang, Xingwang Li, Bo Yang, Jingdong Song +14 more

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

The Lancet(2020)10.1016/s0140-6736(20)30251-8
N/A
1.4DataRank · unranked
12544 citations

Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu +32 more

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018

Antiviral Research(2020)10.1016/j.antiviral.2020.104718
N/A
0DataRank · unranked
129 citations

Rod S. Daniels, Seiichiro Fujisaki, Vicki L. Gregory, Larisa V. Gubareva, Weiijuan Huang +13 more

Three Cases Infected with Avian Influenza A(H5N6) Virus — Chongqing Municipality, China, January–September, 2021

China CDC Weekly(2022)10.46234/ccdcw2021.278
N/A
0DataRank · unranked
2 citations

Zhen Yu, Yu Lan, Ju Wang, Shuang Chen, Qi Li +13 more

Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020–2023

Antiviral Research(2025)10.1016/j.antiviral.2025.106217
N/A
0DataRank · unranked
17 citations

Adam Meijer, Elena A. Govorkova, Clyde Dapat, Larisa V. Gubareva, Ian Barr +20 more